SUSAN MCKIM: Open Payments
NPI 1003817578 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,711 in 79 payments from 17 companies in 2025. Trend: 2023 $1,675 · 2024 $1,783 · 2025 $1,711
Food & beverage: $1,711
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $285 |
| PFIZER INC. | 12 | $242 |
| Janssen Biotech, Inc. | 9 | $224 |
| UCB, Inc. | 8 | $141 |
| Janssen Scientific Affairs, LLC | 1 | $138 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $93 |
| Amgen Inc. | 5 | $92 |
| Arcutis Biotherapeutics, Inc. | 4 | $82 |
| Incyte Corporation | 3 | $79 |
| Lilly USA, LLC | 3 | $70 |
Products named: TREMFYA, CIBINQO, RINVOQ, Bimzelx, SKYRIZI, OTEZLA, Zoryve, DUPIXENT.
Industry payments across CA — which companies pay providers there.
